Former FDA medical officer urges withdrawal of Prader-Willi drug Vykat XR

A former FDA medical officer urges withdrawal of the Prader-Willi drug Vykat XR, the FDA approves pritelivir for refractory herpes, and peptide users report harms as an FDA panel backs wider compounding access.